Edwards Lifesciences price target lowered to $77 from $85 at Canaccord
PremiumThe FlyEdwards Lifesciences price target lowered to $77 from $85 at Canaccord
1d ago
Edwards Lifesciences downgraded to Neutral at BofA on growth concerns
PremiumThe Fly
Edwards Lifesciences downgraded to Neutral at BofA on growth concerns
1d ago
Edwards Lifesciences downgraded to Neutral from Buy at BofA
PremiumThe Fly
Edwards Lifesciences downgraded to Neutral from Buy at BofA
1d ago
Edwards Lifesciences downgraded to Hold from Buy at Truist
PremiumThe FlyEdwards Lifesciences downgraded to Hold from Buy at Truist
1d ago
Edwards Lifesciences downgraded to Neutral from Overweight at JPMorgan
PremiumThe Fly
Edwards Lifesciences downgraded to Neutral from Overweight at JPMorgan
1d ago
Edwards Lifesciences Bolsters Cardiac Care with Key Acquisitions
PremiumCompany Announcements
Edwards Lifesciences Bolsters Cardiac Care with Key Acquisitions
2d ago
EW Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsEW Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4d ago
Edwards Lifesciences price target raised to $110 from $105 at Truist
PremiumThe Fly
Edwards Lifesciences price target raised to $110 from $105 at Truist
10d ago
Edwards Lifesciences Expands with Innovalve Acquisition Deal
PremiumCompany Announcements
Edwards Lifesciences Expands with Innovalve Acquisition Deal
11d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100